Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Ann Neurol. 2022 Jul 11;92(3):425–438. doi: 10.1002/ana.26438

Table 4:

Statistics for longitudinal slopes of decline by pathologic feature and their interaction with group

PART vs ADNC Braak I-II vs Braak III-IV LATE-NC− vs LATE-NC + Vasc− vs Vasc+
Coefficient (95% CI) Group P value Coefficient (95% CI) Braak P value Group Interaction P value Coefficient (95% CI) LATE P value Group Interaction P value Coefficient (95% CI) Vasc P value Group Interaction P value
MMSE −0.16 (−1.11 – 0.79) 0.752 1.31 (−2.40 – −0.32) 0.019 0.289 1.89 (−3.04 – −0.84) 0.002 0.706 −0.34 (−1.52 – 0.74) 0.562 0.309
DRS 0.12 (−3.77 – 4.08) 0.952 −4.07 (−8.42 – −0.06) 0.066 0.258 7.76 (−12.74 – −3.36) 0.002 0.546 5.18 (−10.18 – −0.63) 0.037 0.194
CDR-sob 0.61 (−0.81 – 2.08) 0.439 2.77 (1.47 – 4.18) <0.001 0.417 1.93 (0.38 – 3.66) 0.029 0.202 0.55 (−0.75 – 1.91) 0.455 0.838
Memory 0.14 (−0.14 – 0.43) 0.351 −0.4 (−0.72 – −0.10) 0.015 0.409 0.03 (−0.31 – 0.35) 0.864 0.375 −0.01 (−0.37 – 0.36) 0.951 0.555
Executive 0.15 (−0.25 – 0.56) 0.471 0.00 (−0.44 – 0.45) 0.998 0.619 −0.06 (−0.55 – 0.44) 0.829 0.769 −0.40 (−0.92 – 0.13) 0.151 0.829
Visuospatial −0.02 (−0.49 – 0.46) 0.952 −0.01 (−0.53 – 0.50) 0.977 0.529 −0.19 (−0.78 – 0.39) 0.540 0.935 0.00 (−0.61 – 0.59) 0.990 0.066
Language −0.21 (−0.52 – 0.09) 0.194 −0.12 (−0.46 – 0.22) 0.517 0.539 0.48 (−0.84 – −0.13) 0.013 0.757 0.02 (−0.39 – 0.41) 0.921 0.742

For each cognitive test or composite, the coefficient (99% Confidence Interval) for the annualized rate of decline is provided along with the p value for each pathologic term as indicated along the top. For each pathologic term other than the Group term (i.e., PART vs ADNC), the p value for the interaction of the pathologic term with Group is also provided so assess if the effects differ between those with PART or ADNC.